Keywords: Neuroregenerative diseases, Alzheimer's, Research, USA, NIH, Merck & Co, Johnson & Johnson

Researchers funded by Merck & Co/Johnson & Johnson identify potential new drug for neurodegenerative disease

Article | 10 September 2010

Print This

Scientists have discovered a small molecule that helps human cells get rid of the misfolded, disfigured proteins implicated in Alzheimer& ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in